The company has significantly advanced this progress of an new treatment for amyloid heart disease, employing Attruby. Early trial data reveals significant improvements for patients affected by the debilitating https://attruby980221.techionblog.com/42371411/bridgebio-advances-attr-cm-management-using-the-drug